Sergio Lavilla-Alonso

Independent life sciences consultant and former Project Leader (Almirall, Genmab) with 10+ years’ experience across biotech and pharma. Focus on biologics, particularly bispecific antibodies, with additional experience in gene therapy. Background in dermatology, immunology, and immuno‑oncology. I support biotech and pharma teams with strategic input on early development, asset evaluation, and program design.

▪ Led a multidisciplinary Discovery Team to deliver the full Candidate Readiness Package for an anti‑IL‑13/OX40L bispecific antibody, enabling its transition into the Development phase (Preclinical Candidate Nomination) in 2023. Later, I served as Disease Biology representative collaborating on IND/enabling studies. The asset is now in the pipeline, and I am a listed inventor on the patent.

▪ Generated innovative concepts for new targets and therapeutic approaches, leading small teams to develop Discovery Packages and, when needed, coordinating scientific collaborations with academic groups and industry partners.

▪ Contributed to the assessment of external opportunities by supporting due‑diligence evaluations of small molecules, biologics, and gene‑therapy assets.

▪ Contributed to the development of translational research projects and patient-focused clinical trial

research programs, including securing grant funding and coordinating the writing of manuscripts for

publication in scientific journals

▪ Successfully obtained Certificate for the course “ICH-GCP: a guideline for good clinical practice (GCP

Elevate 2020/04)”